A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice

Heart

Volumn 102, Issue 11, 2016, Pages 855-861

  Troeung, Lakkhina ^a   Arnold Reed, Diane ^a   Ping Delfos, Wendy Chan She ^a   Watts, Gerald F ^b,c   Pang, Jing ^b,c   Lugonja, Marija ^d   Bulsara, Max ^a   Mortley, David ^d   James, Matthew ^a,e,f   Brett, Tom ^a,d  

^a UNIVERSITY OF NOTRE DAME   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Mosman Park Medical Group   (Australia)

^e PORT MACQUARIE BASE HOSPITAL   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADULT; ARTICLE; AUSTRALIA; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; ELECTRONIC SCREENING TOOL; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOLLOW UP; GENERAL PRACTICE; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; AGED; BLOOD; COST BENEFIT ANALYSIS; DATA MINING; ECONOMICS; ELECTRONIC HEALTH RECORD; EVALUATION STUDY; HEALTH CARE COST; HYPERLIPOPROTEINEMIA TYPE II; MASS SCREENING; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; TIME FACTOR; WESTERN AUSTRALIA; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; CHOLESTEROL; CHOLESTEROL, LDL; COST-BENEFIT ANALYSIS; DATA MINING; ELECTRONIC HEALTH RECORDS; FEMALE; GENERAL PRACTICE; HEALTH CARE COSTS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 84959108827     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-308824     Document Type: Article

References (29)

1. Austin MA, Hunter CM, Zimmern RL, et al. Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review. Am J Epidemiol 2004;160:407-20.
2. Austin MA, Hunter CM, Zimmern RL, et al. Familial hypercholesterolemia and coronary heart disease: A HuGE association review. Am J Epidemiol 2004;160:421-9.
3. Doust J, Miller E, Duchesne G, et al. A systematic review of brachytherapy. Is it an effective and safe treatment for localised prostate cancer? Aust Fam Physician 2004;33:525-9.
4. Kirke AB, Barbour RA, Burrows S, et al. Systematic detection of familial hypercholesterolaemia in primary health care: A community based prospective study of three methods. Heart Lung Circ 2015;24:250-6.
5. Vickery AW, Bell D, Garton-Smith J, et al. Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services. Heart Lung Circ 2014;23:1158-64.
6. Watts GF, Sullivan DR, Poplawski N, et al. Familial hypercholesterolaemia: A model of care for Australasia. Atheroscler Suppl 2011;12:221-63.
7. Kirke A, Watts GF, Emery J. Detecting familial hypercholesterolaemia in general practice. Aust Fam Physician 2012;41:965-8.
8. Qureshi N, Humphries SE, Seed M, et al. Identification and management of familial hypercholesterolaemia: what does it mean to primary care? Br J Gen Pract 2009;59:773-8.
9. Bell DA, Kirke AB, Barbour R, et al. Can patients be accurately assessed for familial hypercholesterolaemia in primary care? Heart Lung Circ 2014;23:1153-7.
10. Wald DS, Bestwick JP, Wald NJ. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. BMJ 2007;335:599.
11. Brett T, Watts GF, Garton-Smith J, et al. Familial hypercholesterolaemia: challenges in primary care. Med Today 2015;16:20-6.
12. Brett T, Watts GF, Arnold-Reed DE, et al. Challenges in the care of familial hypercholesterolemia: A community care perspective. Expert Rev Cardiovasc Ther 2015;13:1091-100.
13. National Heart Lung and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. US Department of Health and Human Services, National Institutes of Health. Report Number 12.7486, 2012.
14. Marks D, Wonderling D, Thorogood M, et al. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ 2002;324:1303-8.
15. Gray J, Jaiyeola A, Whiting M, et al. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart 2008;94:754-8.
16. McInnes DK, Saltman DC, Kidd MR. General practitioners' use of computers for prescribing and electronic health records: results from a national survey. Med J Aust 2006;185:88-91.
17. World Health Organisation. Familial Hypercholesterolaemia. Report of a second WHO consultation. Geneva: World Health Organisation, 1999.
18. Weng SF, Kai J, Neil HA, et al. Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT). Atherosclerosis 2015;238:336-43.
19. Best Practice Software. Best Practice: an evolution in GP software. Secondary Best Practice: an evolution in GP software 2015. http://www.bpsoftware.net/
20. Royal Australian College of General Practitioners. Standards for general practices (4th edition) including interpretive guide for Aboriginal and Torres Strait Islander health services: glossary of terms. Secondary Standards for general practices (4th edition) including interpretive guide for Aboriginal and Torres Strait Islander health services: glossary of terms 2015. http://www.racgp.org.au/your-practice/standards/standards4thedition/appendices/glossary-of-terms/
21. Haralambos K, Whatley SD, Edwards R, et al. Clinical experience of scoring criteria for familial hypercholesterolaemia (FH) genetic testing in Wales. Atherosclerosis 2015;240:190-6.
22. National Institute for Health and Clinical Excellence and The National Collaborating Centre for Primary Care. ICE Clinical Guideline 71: Identification and management of familial hypercholesterolaemia. National Collaborating Centre for Primary Care: Royal College of General Practitioners; London: 2008.
23. Statistics AB. Consumer Price Index Inflation Calculator. Secondary Consumer Price Index Inflation Calculator 2015. http://www.abs.gov.au/websitedbs/d3310114.nsf/home/Consumer+Price+Index+Inflation+Calculator
24. Ademi Z, Watts GF, Pang J, et al. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia. J Clin Lipidol 2014;8:390-400.
25. Board MSR. A resource-based model of private medical practice in Australia-final report. Canberra, ACT, Australia: Pricewaterhouse Coopers, 2000.
26. Brett TD, Arnold-Reed DE, Phan CT, et al. Work intentions and opinions of general practice registrars. Med J Aust 2009;191:73-4.
27. Brett TD, Arnold-Reed DE, Hince DA, et al. Retirement intentions of General Practitioners aged 45-65 years. Med J Aust 2009;191:75-7.
28. Brett T, Arnold-Reed D, Phan C, et al. Capacity census-a pilot study of general practices in Western Australia. Aust Fam Physician 2011;40:753-4.
29. Watts GF, Gidding S, Wierzbicki AS, et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol 2014;171:309-25.